TM6SF2 and metabolic dysfunction-associated steatotic liver disease: However, some NAFLD-associated SNPs have impaired VLDL secretion (TM6SF2 and PNPLA3 (patatin-like phospholipase domain containing 3), and also MTTP and PEMT), thus decreasing plasma lipids and providing a cardioprotective effect [191].